Results
|
|
461.
|
|
|
|
462.
|
|
|
|
463.
|
|
|
|
464.
|
SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug. [electronic resource] by
- McCreary, Andrew C
- Glennon, Jeffrey C
- Ashby, Charles R
- Meltzer, Herbert Y
- Li, Zhu
- Reinders, Jan-Hendrik
- Hesselink, Mayke B
- Long, Stephen K
- Herremans, Arnoud H
- van Stuivenberg, Herman
- Feenstra, Rolf W
- Kruse, Chris G
Producer: 20070209
In:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology vol. 32
Availability: No items available.
|
|
|
465.
|
|
|
|
466.
|
|
|
|
467.
|
|
|
|
468.
|
|
|
|
469.
|
|
|
|
470.
|
|
|
|
471.
|
|
|
|
472.
|
|
|
|
473.
|
|
|
|
474.
|
|
|
|
475.
|
|
|
|
476.
|
|
|
|
477.
|
|
|
|
478.
|
|
|
|
479.
|
|
|
|
480.
|
|